{
  "id": 361,
  "text": "An eighth edition of the TNM classification4 of malignant tumours as been published in december 2016.The FIGO staging system was last reviewed in 2009 by the FIGO Committee on gynecologic oncology5-7 in close collaboration with the American joint commission on cancer and the Union of international cancer control (Table 7).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: An eighth edition of the TNM classification4 of malignant tumours as been published in december 2016.The FIGO staging system was last reviewed in 2009 by the FIGO Committee on gynecologic oncology5-7 in close collaboration with the American joint commission on cancer and the Union of international cancer control (Table 7).\n\n<question>: ",
  "ChatGPT_response_0": "在评估恶性肿瘤时，TNM分类和FIGO分期系统是非常重要的工具。TNM分类系统涵盖了肿瘤的原发灶大小（T）、淋巴结转移（N）和远处转移（M），有助于医生确定患者的病情严重程度。而FIGO分期系统主要应用于妇科肿瘤的评估，包括子宫颈癌、子宫内膜癌等。这些系统可以帮助医生确定患者病情的严重程度和预后，进而指导治疗方案的制定。通过TNM分类和FIGO分期系统的准确评估，医生可以更好地选择合适的治疗方案，提高患者的治疗效果和生存率。在癌症的诊断和治疗中，这些分类和分期系统起着至关重要的作用。",
  "query": "在评估恶性肿瘤时，您是否了解过TNM分类和FIGO分期系统的重要性？您认为这些分类和分期系统对于癌症的诊断和治疗有多大帮助？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在评估恶性肿瘤时，您是否了解过TNM分类和FIGO分期系统的重要性？您认为这些分类和分期系统对于癌症的诊断和治疗有多大帮助？\n\n<reference text>: An eighth edition of the TNM classification4 of malignant tumours as been published in december 2016.The FIGO staging system was last reviewed in 2009 by the FIGO Committee on gynecologic oncology5-7 in close collaboration with the American joint commission on cancer and the Union of international cancer control (Table 7).\n\n<reply>: ",
  "response": "在评估恶性肿瘤时，TNM分类和FIGO分期系统是非常重要的工具。TNM分类系统涵盖了肿瘤的原发灶大小（T）、淋巴结转移（N）和远处转移（M），有助于医生确定患者的病情严重程度。而FIGO分期系统主要应用于妇科肿瘤的评估，包括子宫颈癌、子宫内膜癌等。这些系统可以帮助医生确定患者病情的严重程度和预后，进而指导治疗方案的制定。通过TNM分类和FIGO分期系统的准确评估，医生可以更好地选择合适的治疗方案，提高患者的治疗效果和生存率。在癌症的诊断和治疗中，这些分类和分期系统起着至关重要的作用。"
}